Varicella-zoster virus

Clinical Microbiology Reviews

Volumn 9, Issue 3, 1996, Pages 361-381

  Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ANTIVIRUS AGENT; CHICKENPOX VACCINE; FAMCICLOVIR; FOSCARNET; IMMUNOGLOBULIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; SORIVUDINE; VALACICLOVIR;

CELLULAR IMMUNITY; CHICKENPOX; COMPLICATION; FEVER; HERPES ZOSTER; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; NONHUMAN; REVIEW; SERODIAGNOSIS; SKIN DEFECT; VARICELLA ZOSTER VIRUS; VIREMIA; VIRION; VIRUS DIAGNOSIS; VIRUS NUCLEOCAPSID;

GALLUS GALLUS; HERPES; HERPES ZOSTER; HUMAN HERPESVIRUS 3; MIRIDAE;

EID: 0030055588     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.9.3.361-381.1996     Document Type: Review

References (270)

1. Alessi, E., M. Cusini, R. Zerboni, S. Calvicchini, C. Uberti-Foppa, M. Galli, and M. Moroni. 1988. Unusual varicella zoster virus infection in patients with the acquired immunodeficiency syndrome. Arch. Dermatol. 124:1011-1013.
2. American Academy of Pediatrics Committee on Infections Diseases. 1993. The use of oral acyclovir in otherwise healthy children with varicella. Pediatrics 91:674-676.
3. American Academy of Pediatrics Committee on Infectious Diseases. 1995. Recommendations for the use of live attenuated varicella vaccine. Pediatrics 95:791-796.
4. Amlie-Lefond, C., D. K. Kleinschmidt-DeMasters, R. Mahalingam, L. E. Davis, and D. H. Gildes. 1995. The vasculopathy of varicella-zoster virus encephalitis. Ann. Neurol. 37:784-790.
5. Anderson, D. R., J. Schwartz, N. J. Hunter, C. Cottrill, E. Bisaccia, and A. S. Klainer, 1994. Varicella hepatitis: a fatal case in a previously healthy immunocompetent adult. Report of a case, autopsy, and review of the literature. Arch. Intern. Med. 154:2101-2106.
6. Arbeter, A. M., S. E. Starr, and S. A. Plotkin. 1986. Varicella vaccine studies in healthy children and adults. Pediatrics 78:748-756.
7. Arvin, A. M. 1992. Cell-mediated immunity to varicella-zoster virus. J. Infect. Dis. 166(Suppl. 1):S35-S41.
8. Arvin, A. M. 1995, Varicella-zoster virus, p. 2547-2586. In B. Fields (ed.), Virology, 3rd ed. Raven Press, New York.
9. Arvin, A. M., E. Kinney-Thomas, K. Shriver, C. Grose, C. M. Koropchak, E. Scranton, A. E. Wittek, and P. S. Diaz. 1986. Immunity to varicella-zoster viral glycoproteins, gpI (gp90/58), gpIII (gp118), and to nonglycosylated protein. J. Immunol. 137:1346-1351.
10. Arvin, A. M., C. M. Koropchak, B. R. G. Williams, F. C. Grumet, and S. K. H. Foung, 1986. The early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J. Infect. Dis. 154:422-429.
11. Arvin, A. M., C. M. Koropchak, and A. E. Wittek, 1983. Immunologic evidence for reinfection with varicella-zoster virus. J. Infect. Dis. 148:200-205.
12. Arvin, A. M., J. H. Kushner, S. Feldman, R. L. Bachner, D. Hammand, and T. C. Merigan. 1882. Human leukocyte interferon for the treatment of varicella in children with cancer. N. Engl. J. Med. 306:761-765.
13. Arvin, A. M., M. Sharp, S. Smith, C. M. Koropchak, P. S. Diaz, P. Kinchington, W. Ruyechan, and J. Hay. 1991. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T-lymphocytes of either CD4+ or CD8+ phenotype. J. Immunol. 146:257-264.
14. Asano, Y., N. Itakura, Y. Hiroishi, S. Hirose, T. Nagai, T. Ozaki, T. Yazaki, K. Yamanishi, and M. Takahashi. 1985. Viremia is present in incubation period in nonimmunocompromised children with varicella. J. Infect. Dis. 106:68-71.
15. Asano, Y., N. Itakura, T. Hiroishi, S. Hirose, T. Ozaki, K. Kuno, T. Nagai, T. Yazaki, K. Yamanishi, and M. Takahashi. 1985. Viral replication and immunologic responses in children naturally infected with varicella-zoster and in varicella vaccine recipients. J. Infect Dis. 152:863-868.
16. Asano, Y., N. Itakura, Y. Kajita, S. Suga, T. Yoshitawa,T. Yazaki, T. Ozaki, K. Yamanishi, and M. Takahashi. 1990. Severity of viremia and clinical findings in children with varicella. J. Infect. Dis. 161:1095-1098.
17. Asano, Y., H. Nakayama, T. Yazaki, R. Kato, and S. Hirose. 1977. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics 59:3-7.
18. Asano, Y., S. Saga, T. Yoshikawa, I. Kobayashi, T. Yazaki, M. Shibata, K. Tsuzuki, and S. Ito. 1994. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics 94:524-526.
19. Balducci, J., J. F. Rodis, S. Rosengren, A. M. Vintzileos, G. Spivey, and C. Vossller. 1992. Pregnancy outcome following first-trimester varicella infection. Obstet. Gynecol. 79:5-6.
20. Balfour, H. H., Jr. 1988. Varicella zoster virus infections in immunocom-promised hosts. A review of the natural history and management Am. J. Med. 85:68-73.
21. Balfour, H. H., Jr., C. Benson, R. Braun, B. Cassens, A. Erice, A. FriedmanKien, T. Klein, B. Polsky, and S. Safrin. 1994. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. J. Acquired Immune Defic. Syndr. 7:254-260.
22. Balfour, H. H., Jr., H. A. Rotbart, S. Feldman, L. M. Dunkle, H. M. Feder, Jr., C. G. Prober, G. F. Hayden, S. Steinberg, R. J. Whitley, L. Goldberg, and The Collaborative Acyclovir Varicella Study Group. 1992. Acyclovir treatment of varicella in otherwise healthy adolescents. J. Pediatr. 120:627-633.
23. Barnes, D. W., and R. J. Whitley. 1986. CNS diseases associated with varicella-zoster virus and herpes simplex virus infections: pathogenesis and current therapy. Neurol. Clin. 4:265-283.
24. Bennett, G. J. 1994. Hypotheses on the pathogenesis of herpes zoster-associated pain. Ann. Neurol. 35:S38-S41.
25. Bergen, R. E., M. Sharp, A. Sanchez, A. K. Judd, and A. M. Arvin. 1991. Human T-cells recognize multiple epitopes of a major tegument/immediate early protein (IE62) and glycoprotein I of varicella-zoster virus. Viral Immunol. 4:151-166.
26. Berger, R., G. Florent, and M. Just. 1981. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged. Infect Immun. 32:24-27.
27. Beutner, K. R., D. J. Friedman, C. Forszpaniak, P. L. Andersen, and M. J. Wood. 1995. Valaciciovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob. Agents Chemother. 39:1546-1553.
28. Biron, K. K., and G. B. Elion. 1980. In vitro susceptibility of varicella-zoster virus to acyclovir. Antimicrob. Agents Chemother. 18:443-447.
29. Bogger-Goren, S., K. Baba, P. Hurley, H. Yabunchi, M. Takabashi, and P. L. Ogra. 1982. Antibody responses to varicella-zoster virus after natural or vaccine-induced infection. J. Infect. Dis. 146:260-264.
30. Bogger-Goren, S., J. M. Bernstein, A. A. Gershon, and P. L. Ogra. 1984. Mucosal cell-mediated immunity to varicella-zoster virus: role in protection against disease. J. Pediatr. 105:195-199.
31. Boivin, G., C. K. Edelman, L. Pedneault, C. L. Talarico, K. K. Biron, and H. H. Balfour, Jr. 1994. Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster viruses isolated from persons with AIDS. J. Infect Dis. 170:68-75.
32. Brinker, J. P., and G. V. Doern. 1993. Comparison of MRC-5 and A-549 cells in conventional culture tubes and shell vial assays for the detection of varicella-zoster virus. Diagn. Microbiol. Infect. Dis. 17:75-77.
33. Brunell, P. A. 1989. Transmission of chickenpox in a school setting prior to the observed exanthem. Am. J. Dis. Child. 143:1451-1452.
34. Brunell, P. A. 1992. Varicella in pregnancy, the fetus and the newborn: problems in management. J. Infect. Dis. 166(Suppl. 1):S42-S47.
35. Brunell, P. A., A. A. Gershon, S. A. Uduman, and S. Steinberg. 1975. Varicella-zoster immunoglobulin during varicella, latency, and zoster. J. Infect. Dis. 132:49-54.
36. Buchbinder, S. P., M. H. Katz, N. A. Hessol, J. Y. Liu, P. M. O'Malley, R. Underwood, and S. D. Holmberg. 1992. Herpes zoster and human immunodeficiency virus infection. J. Infect. Dis. 166:1153-1156.
37. Bullowa, J. G. M., and S. M. Wishik. 1935. Complications of varicella. I. Their occurrence among 2534 patients. Am. J. Dis. Child. 49:923-926.
38. Centers for Disease Control. 1984. Varicella-zoster immune globulin for the prevention of chickenpox: recommendations of the immunizations practices advisory committee. Ann. Intern. Med. 100:859-865.
39. Cohen, J. I., and K. E. Seidel. 1993. Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc. Natl. Acad. Sci. USA 90:7376-7380.
40. Cohen, J. I., and K. Seidel. 1994. Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro. J. Virol. 68:7850-7858.
41. Cohen, J. I., and S. E. Straus. 1995. Varicella-zoster virus and its replication, p. 2525-2546. In B. Fields (ed.), Virology, 3rd ed. Raven Press, New York.
42. Cohen, P. R., and M. E. Grossman. 1989. Clinical features of human immunodeficiency virus-associated disseminated herpes zoster virus infection - a review of the literature. Clin. Exp. Dermatol. 14:273-276.
43. Cohrs, R., R. Mahalingam, A. N. Dueland, W. Wolf, M. Wellish, and D. H. Gilden. 1992. Restricted transcription of varicella-zoster virus in latently infected human trigeminal and thoracic ganglia. J. Infect Dis. 166(Suppl. 1):S24-S29.
44. Cohrs, R. J., M. B. Barbour, R. Mahalingam, M. Wellish, and D. H. Gilden. 1995. Varicella-zoster virus (VZV) transcription during latency in human ganglia: prevalence of VZV gene 21 transcripts in latently infected human ganglia. J. Virol. 69:2674-2678.
45. Cobrs, R. J., K. Stock, M. B. Barbour, G. Owens, R. Mahalingam, M. E. Devlin, M. Wellish, and D. H. Gilden. 1994. Varicella-zoster virus (VZV) transcription during latency in human ganglia: construction of a cDNA library from latently infected human trigeminal ganglia and detection of a VZV transcript J. Virol. 68:7900-7908.
46. Colebunders, R., J. M. Mann, H. Francis, K. Bila, L. Izaley, M. Ilwaya, N. Kakanda, T. C. Quinn, J. W. Curran, and P. Piot. 1988. Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection. J. Infect. Dis. 157:314-318.
47. Committee on Infections Diseases. 1994. Varicella-zoster infections, 22nd ed., p. 510-516. American Academy of Pediatrics, Elk Grove Village, III.
48. Connelly, B. L., L. R. Stanberry, and D. I. Bernstein. 1993. Detection of varicella-zoster virus DNA in nasopharyngeal secretions of immune household contacts of varicella. J. Infect. Dis. 168:1253-1255.
49. Cowan, M. R., P. A. Primm, S. M. Scott, T. J. Abramo, and R. A. Wicbe. 1994. Serious group A beta-hemolytic streptococcal infections complicating varicella. Ann. Emerg. Med. 23:818-822.
50. Croen, K. D., J. M. Ostrove, L. J. Dragovic, and S. E. Straus. 1998. Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc. Natl. Acad. Sci USA 85:9773-9777.
51. Cuthbertson, G., and C. Grose. 1988. Biotinylated and radioactive DNA probes for detection of varicella-zoster virus genome in infected human cells. Mol. Cell. Probes 2:197-207.
52. Davison, A. J., C. M. Edson, R. W. Ellis, B. Forghani, D. Gilden, C. Grose, P. M. Keller, A. Vafai, Z. Wroblewska, and K. Yamanishi. 1986. A new common nomenclature for the glycoprotein genes of varicella-zoster virus and their glycosylated products. J. Virol. 57:1195-1197.
53. Davison, A. J., and J. E. Scott. 1986. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1759-1816.
54. Debrus, S., C. Sadzot-Delvaux, A. F. Nikkeis, J. Piette, and B. Rentier. 1995. Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J. Virol. 69:3240-3245.
55. Denny-Brown, D., R. D. Adams, and P. J. Fitzgerald. 1944. Pathologic features of herpes zoster. A note on "geniculate herpes." Arch. Neurol. Psychol. 51:216-231.
56. Devlin, M. E., D. H. Gliden, R. Mahalingam, A. N. Dueland, and R. Cohrs. 1992. Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA. J. Infect. Dis. 165:619-622.
57. Diaz, P. S., D. Au, S. Smith, M. Amyion, M. Link, and A. M. Arvin. 1991. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings. Pediatrics 87:166-170.
58. Dolin, R., R. C. Reichman, M. H. Mazur, and R. J. Whitley. 1978. Herpes zoster-varicella infection in immunosuppressed patients. Ann. Intern. Med. 89:375-388.
59. Drew, W. L., and L. Mintz. 1980. Rapid diagnosis of varicella-zoster virus infection by direct immunofluorescence. Am. J. Clin. Pathol. 73:699-701.
60. Dueland, A. N., M. Devlin, R. J. R. Martin, R. Mahalingam, R. Cohrs, H. Manz, I. Trombley, and D. Gilden. 1991. Fatal varicella-zoster virus meningoradiculitis without skin involvement. Ann. Neurol. 29:569-572.
61. Dunkle, L. M., A. M. Arvin, R. J. Whitley, H. A. Rotbart, H. M. Feder, Jr., S. Feldman, A. A. Gershon, M. L. Levy, G. F. Hayden, and P. V. McGuirt. 1991. A controlled trial of acyclovir for chickenpox in normal children. N. Engl. J. Med. 325:1539-1544.
62. Dworsky, M., R. J. Whitley, and C Alford. 1980. Herpes zoster in early infancy. Am. J. Dis. Child. 134:618-620.
63. Earnsbaw, D. L., T. H. Bacon, S. J. Darlison, K. Edmonds, R. M. Perkin, and R. A. Vere Hodge. 1992. Mode of antiviral action of penciclovir in MRC-5 cell infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrob. Agents Chemother. 36:2747-2757.
64. Edwards, T. S. 1989. Ophthalmic complications from varicella. J. Pediatr. Ophthalmol. 965:37-44.
65. Enders, G., E. Miller, J. Cradock-Watson, I. Bolley, and M. Ridehalgh. 1994. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 343:1548-1551.
66. Englund, J. A., A. M. Arvin, and H. Balfour. 1990. Acyclovir treatment for varicella does not lower gpI and IE-62 (p170) antibody responses to varicella-zoster virus in normal children. J. Clin. Microbiol. 28:2327-2333.
67. Englund, J. A., C. S. Suarez, J. Kelly, D. Y. Tate, and H. H. Balfour, Jr. 1989. Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine. J. Pediatr. 114:37-44.
68. Esiri, M. M., and A. H. Tomlinson. 1972. Herpes zoster, demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and electron microscopy. J. Neurol. Sci. 15:35-48.
69. Esmann, V., J. P. Geil, S. Kroon, Fogh, N. A. Piterslund, C. S. Petersen, J. O. Ronne-Rasmussen, and L. Danielsen. 1987. Prednisolone does not prevent post-herpetic neuralgia. Lancet 2:126-129.
70. Ey, J. L., and V. A. Fulginiti. 1981. Varicella hepatitis without neurologic symptoms or findings. Pediatrics 67:258-263.
71. Feldhoff, C. M., H. H. Balfour, R. L. Simmons, J. S. Najarian, and S. M. Mauer. 1987. Varicella in children with renal transplants. J. Pediatr. 98:25-29.
72. Feldman, S., W. T. Hughes, and H. Y. Kim. 1973. Herpes zoster in children with cancer. Am. J. Dis. Child. 126:178-194.
73. Feldman, S., and L. Lott. 1987. Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics 80:465-472.
74. Feldman, S. R., M. J. Ford, and R. A. Briggaman. 1988. Herpes zoster and facial palsy. Cutis 42:523-524.
75. Feusner, J. H., S. J. Slichter, and L. A. Harter. 1979. Mechanisms of thrombocytopenia in varicella. Am. J. Hematol. 7:255-262.
76. Fleisher, G., W. Henry, M. Sorley, A. Arbeter, and S. Plotkin. 1981. Life-threatening complications of varicella. Am. J. Dis. Child. 135:896-899.
77. Forghani, B., L. Ni, and C. Grose. 1994. Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology 199:458-462.
78. Forghani, B., G. J. Yu, and J. W. Hurst. 1991. Comparison of biotinylated DNA and RNA probes for rapid detection of varicella-zoster virus genome by in situ hybridization. J. Clin. Microbiol. 29:583-591.
79. Friedman, S. M., C. E. Margo, and B. L. Connelly. 1994. Varicella-zoster virus retinitis as the initial manifestation of the acquired immunodeficiency syndrome. Am. J. Ophthalmol. 117:536-538. (Letter.)
80. Furata, Y., T. Takaso, S. Fukuda, K. C. Stao-Matsumura, Y. Inuyama, R. Hondo, and K. Nagashima. 1992. Detection of varicella-zoster virus DNA in human geniculate ganglia by polymerase chain reaction. J. Infect. Dis. 166:1157-1159.
81. Gershon, A. A. 1991. Human immune responses to live attenuated varicella vaccine. Rev. Infect. Dis. 13(Suppl. 11):S957-S959.
82. Gershon, A. A. 1995. Varicella-zoster virus: prospects for control. Adv. Pediatr. Infect. Dis. 10:93-124.
83. Gershon, A. A., P. A. Brunell, and E. F. Doyle. 1973. Steroid therapy and varicella. J. Pediatr., p. 1032-1039.
84. Gershon, A. A., P. LaRussa, I. Hardy, S. Steinberg, and S. Silverstein. 1991. Varicella vaccine: the American experience. J. Infect. Dis. 166(Suppl. 1): S63-S68.
85. Gershon, A. A., D. L. Sherman, Z. Zhu, C. A. Gabel, R. T. Ambron, and M. D. Gershon. 1994. Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network. J. Virol. 68: 6372-6390.
86. Gershon, A. A., S. Steinberg, and P. A. Brunell. 1974. Zoster immune globulin. A further assessment. N. Engl. J. Med. 290:243-245.
87. Gershon, A. A., S. Steinberg, S. Greenberg, and L. Taber. 1980. Varicella-zoster-associated encephalitis: detection of specific antibody in cerebrospinal fluid. J. Clin. Microbiol. 12:764-767.
88. Gershon, A. A., S. Steinberg, and R. Silber. 1978. Varicella-zoster viremia. J. Pediatr. 92:1033-1036.
89. Gershon, A. A., and S. P. Steinberg. 1979. Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infection. Infect. Immun. 25:170-174.
90. Gershon, A. A., and S. P. Steinberg. 1989. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N. Engl. J. Med. 320:892-897.
91. Gershon, A. A., and S. P. Steinberg. 1990. Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. J. Infect. Dis. 161:661-666.
92. Gershon, A. A., S. P. Steinberg, and L. Geth. 1984. Clinical reinfection with varicella-zoster virus. J. Infect. Dis. 149:137-142.
93. Gershon, A. A., S. P. Steinberg, L. Gelb, G. Galasso, W. Borkowsky, P. Larussa, A. Farrara, and the NIAID Collaborative Varicella Vaccine Study Group. 1984. Live attenuated varicella vaccine: efficacy for children with leukemia in remission. JAMA 252:355-362.
94. Gershon, A. A., S. P. Steinberg, P. LaRussa, A. Ferrara, M. Hammerschlag, and L. Gelb. 1988. Immunization of healthy adults with live attenuated varicella vaccine. J. Infect. Dis. 158:132-137.
95. Gershon, A. A., S. P. Steinberg, and N. J. Schmidt. 1991. Varicella-zoster virus, p. 838-852. In A. Balows, W. J. Hausler, K. L. Herrman, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology. American Society for Microbiology, Washington, D. C.
96. Ghatak, N. R., and H. M. Zimmerman. 1973. Spinal ganglion in herpes zoster. Arch. Pathol. 95:411-455.
97. Gilchrest, B., and H. P. Baden. 1974. Photodistribution of viral exanthems. Pediatrics 54:136-138.
98. Gilden, D. H., B. R. Beinlich, E. M. Rubinstein, E. Stommel, R. Swenson, D. Rubinstein, and R. Mahalingam. 1994. Varicella-zoster virus myelitis: an expanding spectrum. Neurology 44:1818-1823.
99. Gilden, D. H., A. N. Dueland, M. E. Devlin, R. Mahalingam, and R. Cohrs. 1992. Varicella-zoster virus reactivation without rash. J. Infect. Dis. 166(Suppl. 1):S30-S34.
100. Gilden, D. H., R. Malingham, A. N. Dueland, and R. Cohrs. 1992. Herpes zoster pathogenesis and latency. Prog. Med. Virol. 39:19-75.
101. Gilden, D. H., R. R. Wright, S. A. Schneck, J. M. Gwaltney, Jr., and R. Mahalingam. 1994. Zoster sine herpete, a clinical variant. Ann. Neurol. 35:530-533.
102. Giller, R. H., S. Winistorfer, and C. Grose. 1989. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects. J. Infect. Dis. 160:919-928.
103. Gleaves, C. A., C. F. Lee, C. I. Bustamante, and J. D. Meyers. 1988. Use of murine monoclonal antibodies for laboratory diagnosis of varicella-zoster virus infection. J. Clin. Microbiol. 26:1623-1625.
104. Gnann, J. W., Jr. 1994. New antivirals with activity against varicella-zoster virus. Ann. Neurol. 35:S69-S72.
105. Gogos, C. A., H. P. Bassaris, and A. G. Vagenakis. 1992. Varicella pneumonia in adults. A review of pulmonary manifestations, risk factors and treatment Respiration 59:339-343.
106. Gold, E. 1966. Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection. N. Engl. J. Med. 274:181-185.
107. Goodpasture, E. W., and K. Anderson. 1944. Infection of human skin, grafted on the chorioallantois of chick embryos with the virus of herpes zoster. Am. J. Pathol. 20:447-455.
108. Gray, F., L. Belec, M. C. Leses, F. Chretien, A. Ciardi, D. Hassiae, M. Flament-Saillour, P. de Truchis, B. Clair, and F. Scaravilli. 1994. Varicella-zoster virus infection of the central nervous system in the acquired immunodeficiency syndrome. Brain 117:987-999.
109. Gray, W. L., C. Y. Pumphrey, W. T. Ruyechan, and T. M. Fletcher. 1992. The simian varicella virus and varicella zoster virus genomes are similar in size and structure. Virology 186:562-572.
110. Grose, C. 1981. Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics 68:735-737.
111. Grose, C. 1991. Glycoproteins of varicella-zoster virus and their herpes simplex virus homologs. Rev. Infect. Dis. 13(Suppl. 11):S960-S963.
112. Grose, C., and T. I. Ng. 1992. Intracellular synthesis of varicella-zoster virus. J. Infect. Dis. 166(Suppl. 1):S7-S12.
113. Grossman, M. C., and M. E. Grossman. 1993. Chronic hyperkeratotic herpes zoster and human immunodeficiency virus infection. J. Am. Acad. Dermatol. 28:306-308.
114. Guess, H. A., D. D. Broughton, L. J. Melton, and L. T. Kurland. 1985. Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics 76:512-518.
115. Guess, H. A., D. D. Broughton, L. J. Melton II, and L. T. Kurland. 1987. Population-based studies of varicella complications. Pediatrics 78:723-727.
116. Gustafson, T. L., G. B. Lavely, E. R. Brawner, Jr., R. H. Hutcheson, Jr., P. F. Wright, and W. Schaffner. 1982. An outbreak of airborne nosocomial varicella. Pediatrics 70:550-556.
117. Haake, D. A., P. C. Zakowski, D. L. Haake, and Y. J. Bryson. 1990. Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review. Rev. Infect. Dis. 12:788-798.
118. Halloran, M. E., S. L. Cochi, T. A. Lieu, M. Wharton, and L. Fehrs. 1994. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am. J. Epidemiol. 140:81-104.
119. Hammerschlag, M. R., A. A. Gershon, S. P. Steinberg, L. Clarke, and L. D. Gelb. 1989. Herpes zoster in an adult recipient of live attenuated varicella vaccine. J. Infect Dis. 160:535-537.
120. Han, C. S., W. Miller, R. Haake, and D. Weisdorf. 1994. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant. 13:277-283.
121. Hardy, L., A. A. Gershon, S. P. Steinberg, and P. LaRussa. 1991. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N. Engl. J. Med. 325:1545-1550.
122. Hayward, A., M. Levin, W. Wolf, G. Angelova, and D, Gilden. 1991. Varicella-zoster virus specific immunity after herpes zoster. J. Infect. Dis. 163: 873-875.
123. Hayward, A. R. 1990. T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV. J. Virol. 64:651-655.
124. Hayward, A. R., and M. Herberger. 1987. Lymphocyte responses to varicella-zoster virus in the elderly. J. Clin. Immunol. 7:174-178.
125. Hayward, A. R., O. Pontesilli, M. Herberger, M. Laszlo, and M. Levin. 1986. Specific lysis of varicella-zoster virus-infected B lymphocytes by human T cells. J. Virol. 58:179-184.
126. Heineman, T. C., and J. L. Cohen. 1994. Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro. J. Virol. 68:3317-3323.
127. Hellinger, W. C., J. P. Bolling, T. F. Smith, and R. J. Campbell. 1993. Varicella-zoster virus retinitis in a patient with AIDS-related complex: case report and brief review of the acute retinal necrosis syndrome. Clin. Infect. Dis. 16:208-212.
128. Hickling, J. K., L. K. Borysiewicz, and J. G. P. Sisson. 1987. Varicella-zoster virus specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood. J. Virol. 61:3463-3469.
129. Hilt, D. C., D. Buchholz, A. Krumholz, and H. Weiss. 1983. Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angitis: diagnosis and management approaches. Ann. Neurol. 14:543-553.
130. 130: Hogan, E. L., and M. R. Krigman. 1973. Herpes zoster myelitis: evidence for viral invasion of spinal cord. Arch. Neurol. 29:309-313.
131. Holbrook, A. A. 1941. The blood picture in chicken pox. Arch. Intern. Med. 60:294-306.
132. Hope-Simpson, R. E. 1965. The nature of herpes zoster: a long-term study and a new hypothesis. Proc. R. Soc. Med. 58:9-20.
133. Huang, Y. C., T. Y. Lin, and C. H. Chiu. 1995. Acyclovir prophylaxis of varicella after household exposure. Pediatr. Infect. Dis. J. 14:152-154.
134. Huff, J. C., B. Bean, H. H. Balfour, Jr., O. L. Laskin, J. D. Connor, L. Corey, Y. J. Bryson, and P. McGuirt. 1988. Therapy of herpes zoster with oral acyclovir. Am. J. Med. 85:84-89.
135. Huff, J. C., J. L. Drucker, A. Clemmer, O. L. Laskin, J. D. Connor, Y. J. Bryson, and H. H. Balfour, Jr. 1993. Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J. Med. Virol. Suppl. 1:93-96.
136. Hughes, P., P. LaRussa, J. M. Pearce, M. Lepow, S. Steinberg, and A. Gershon. 1994. Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reaction. J. Pediatr. 124:932-935.
137. Hurley, J. K., T. Greenslade, P. R. Lewy, Y. Ahmadian, and C. Firlit. 1980. Varicella-zoster infections in pediatric renal transplant recipients. Pediatrics 115:751-757.
138. Hurwitz, I., and R. A. Goodman. 1982. A cluster of cases of Reye syndrome associated with chickenpox. Pediatrics 70:901-910.
139. Ihara, T., H. Kamiya, S. Torigoe, M. Sakurai, and M. Takahashi. 1992. Viremic phase in a leukemic child after live varicella vaccination. Pediatrics 89:147-149.
140. Ilobi, C. P., and B. A. Martin. 1989. A simple and sensitive assay for varicella-zoster virus. J. Virol. Methods 2:137-148.
141. Jacobson, M. A., T. G. Berger, S. Fikrig, P. Becherer, J. W. Moohr, S. C. Stanat, and K. K. Biron. 1990. Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 112:187-191.
142. Jackson, M. A., V. F. Burry, and L. C. Olson. 1992. Complications of varicella requiring hospitalization in previously bealthy children. Pediatrics 2:441-445.
143. Jemsek, J., S. Greenberg, and L. Taber. 1983. Herpes zoster associated encephalitis: clinicopathologic report of 12 cases and review of the literature. Medicine 62:81-88.
144. Johnson, C., L. P. Rome, T. Stancin, and M. L. Kumar. 1989. Humoral immunity and clinical reinfections following varicella vaccine in healthy children. Pediatrics 84:418-421.
145. Johnson, C. E., P. A. Shurin, D. Fattlar, L. P. Rome, and M. I. Kumar. 1988. Live attenuated varicella vaccine in healthy 12- to 24-month-old children. Pediatrics 83:512-518.
146. Johnson, R., and P. E. Milbourne. 1970. Central nervous system manifestations of chickenpox. Can. Med. Assoc. J. 102:831-834.
147. Jura, E., E. G. Chadwick, and S. H. Josephs et al. 1989. Varicella-zoster virus infections in children infected with human immunodeficiency virus. Pediatr. Infect. Dis. J. 8:586-590.
148. Kangro, H. O., A. Ward, S. Argent, R. B. Heath, J. E. Cradock-Watson, and M. K. Ridehalgh. 1988. Detection of specific IgM in varicella and herpes zoster by antibody-capture radioimmunoassay. Epidemiol. Infect. 101:187-195.
149. Kapsenberk, J. G. 1964. Possible antigenic relationship between varicella-zoster virus and herpes simplex virus. Arch. Ges. Virusforsch. 15:67-73.
150. Karbassi, M., M. B. Raizman, and J. S. Schuman. 1992. Herpes zoster ophthalmicus. Surv. Ophthalmol. 36:395-410.
151. Kelley, R., M. Mancao, F. Lee, M. Sawyer, A. Nahmias, and S. Nesheim. 1994. Varicella in children with perinatally acquired human immunodeficiency virus infection. J. Pediatr. 124;271-273.
152. Kinchington, P. R., J. K. Houghland, A. M. Arvin, W. T. Ruyechan, and J. Hay. 1992. Varicella-zoster virus IE62 protein is a major virion component. J. Virol. 66:359-366.
153. Kinchington, P. R., P. Ling, M. Pensiero, B. Moss, W. T. Ruyechan, and J. Hay. 1990. The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka). J. Virol. 64:4540-4548
154. Kinchington, P. R., J. P. Vergnes, J. P. Defechereux, J. Piette, and S. E. Turse. 1994. Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63. J. Virol. 68:3570-3581.
155. Koropchak, C. M., G. Graham, J. Palmer, M. Winsberg, S. F. Ting, M. Wallace, C. G. Prober, and A. M. Arvin. 1991. Investigation of varicella-zoster virus infection by poliymerase chain reaction in the immunocompetent host with acute varicella. J. Infect. Dis. 163:1016-1022.
156. Koropchak, C. M., S. M. Solem, P. S. Diaz, and A. M. Arvin. 1989. Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization. J. Virol. 63:2392-2395.
157. Krugman, S., C. H. Goodrich, and R. Ward. 1957. Primary varicella pneumonia. N. Engl. J. Med. 257:843-847.
158. Kundratitz, K. 1925. Über die Ätiologie des Zoster and über seine Beziehungen zu Varizelien. Wien. Klin. Wochenschr. 38:502-503.
159. Kuter, B. J., R. E. Weibel, H. A. Guess, H. D. Matthews, D. H. Morton, B. J. Neff, P. J. Provost, B. A. Watson, S. E. Starr, and S. A. Plotkia. 1991. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 9:643-647.
160. Kyong, C. U., C. D. Smith, and H. B. Otherson. 1985. Necrotizing fasciitis of the abdominal wall as a complication of chickenpox. Pediatr. Infect Dis. J. 4:420-423.
161. Landry, M. L., S. D. Cohen, D. R. Mayo, C. K. Y. Fong, and W. A. Audiman. 1987. Comparison of fluorescent-antibody-to-membrane-antigen test. indirect immunofluorescence assay, and a commercial enzyme-linked immunosorbent assay for determination of antibody to varicella-zoster virus. J. Clin. Microbiol. 25:832-835.
162. Landry, M. L., and D. Ferguson. 1993. Comparison of latex agglutination test with enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus. J. Clin. Microbiol. 30:3031-3033.
163. LaRussa, P., O. Lungu, I. Hardy, A. Gershon, S. P. Steinberg, and S. Silverstein. 1992. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-tvpe varicella-zoster virus isolates. J. Virol. 6:1016-1020.
164. Lawrence, R., A. A. Gershon, R. Holzman, S. P. Steinberg, and the NIAID Varicella Vaccine Collaborative Study Group. 1988. The risk of zoster after varicella vaccination in children with leukemia. N. Engl. J. Med. 318:543-548.
165. Leboit, P. E., M. Limova, T. S. Yen, J. M. Palefsky, C. R. White, Jr., and T. G. Berger. 1992. Chronic verrucous varicella-zoster virus infection in patients with the acquired immunodeficiency syndrome (AIDS). Histologic and molecular biologic findings. Am. J. Dermatopathol. 14:1-7.
166. Leelair, J. M., J. A. Zaia, M. J. Levin, R. G. Congdon, and D. A. Goldmana. 1980. Airborne transmission of chickenpox in a hospital. N. Engl. J. Med. 302:450-453.
167. Lecuru, F., R. Taurelle, J. P. Bernard, et al. 1994. Varicella zoster virus infection during pregnancy: the limits of prenatal diagnosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 56:67-68.
168. Leibovitz, E., A. Kaul, M. Rigaud, D. Bebenroth, K. Krasinski, and W. Borkowsky. 1992. Chronic varicella zoster in a child infected with human immunodeficiency virus: case report and review of the literature. Cutis 49:27-31.
169. Lever, W. F., and G. Schaumburg-Lever. 1990. Histopathology of the skin, p. 404-406. J. B. Lippincott Co., Philadelphia.
170. Levin, M. J., S. Leventhal, and H. A. Masters. 1984. Factors influencing quantitative isolation of varicella-zoster virus. J. Clin. Microbiol. 50:880-883.
171. Levin, M. J., M. Murray, G. O. Zerbe, C. J. White, and A. R. Hayward. 1994. Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J. Infect Dis. 170:522-526.
172. Liesegang, T. J. 1991. Diagnosis and therapy of herpes zoster ophthalmicus. Ophthalmology 98:1216-1229.
173. Lieu T. A., S. L. Cochi, S. B. Black, M. E. Halloran, H. R. Shinefield, S. J. Holmes, and M. Wharton. 1994. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 271:375-381.
174. Lieu, T. A., L. J. Finkler, M. E. Sorel, S. B. Black, and H. S. Shinefield. 1995. Cost-effectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescents. Pediatrics 95:632-638.
175. Liu, G. T., and D. K. Urion. 1992. Pre-eruptive varicella encephalitis and cerebellar ataxia. Pediatr. Neurol. 8:69-70.
176. Ljungman, P., B. Lonnqvist, O. Ringden, P. Skinhoj, and G. Gahrton. 1989. A randomized trial of oral versus intravenous acyclovir for treatment of herpes zoster in bone marrow transplant recipients. Nordic Bone Marrow Transplant Group. Bone Marrow Transplant 4:613-613.
177. Locksley, R. M., N. Flournoy, M. Sullivan, and J. D. Myers. 1985. Infection with varicella-zoster virus after marrow transplantation. J. Infect. Dis. 152:1172-1181.
178. Lowe, R. S., P. M. Keller, B. J. Keech, A. J. Davison, Y. Whang, A. J. Morgan, E. Kieff, and R. W. Ellis. 1987. Varicella-zoster virus as a live vector for the expression of foreign genes. Proc. Natl. Acad. Sci. USA 84:3896-3900.
179. Lynfield, R., J. T. Herrin, and R. H. Rubin. 1992. Varicella in pediatric renal transplant patients. Pediatrics 90:216-220.
180. Machida, H., and M. Nishitani. 1990. Drug susceptibilities of isolates of varicella-zoster virus in a clinical study of oral brovavir. Microb. Immunol. 34:407-411.
181. Mahalingham, R., M. C. Wellish, A. N. Dueland, R. J. Cohrs, and D. H. Gilden. 1992. Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia. Ann. Neurol. 31:444-448.
182. Mahalingham, R., M. C. Wellish, D. Lederer, B. Forghani, R. Cohrs, and D. Gilden. 1993. Quantitation of latent varicella-zoster virus DNA in human
183. McGregor, R. S., B. J. Zitelli, A. H. Urbach, J. J. Malatack, and J. C. Gartner, Jr. 1989. Varicella in pediatric orthotopic liver transplant recipients. Pediatrics 83:256-261.
184. McKendrick, M. W., J. I. McGill, J. E. White, and M. J. Wood. 1986 Oral acyclovir in acute herpes zoster. Br. Med. J. 293:1529-1532.
185. Medical Letter on Drugs and Therapeutics. 1994. Famciclovir for herpes zoster. Med. Lett. Drugs Ther. 36:97-98.
186. Meir, J. L., R. P. Holman, K. D. Croen, J. E. Smialek, and S. E. Straus. 1993. Varicella-zoster virus transcription in human trigeminal ganglia. Virology 193:193-200.
187. Meyers, J. D., N. Flournoy, and E. D. Thomas. 1980. Cell-mediated immunity to varicella-zoster virus after allogeneic bone marrow transplant. J. Infect. Dis. 141:479-487.
188. Miller, A. E. 1980. Selective decline in cellular immune response to varicella zoster in the elderly. Neurology 30:582-587.
189. Miller, E., J. E. Cradock-Watson, and M. K. Ridehalgh. 1989. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet ii:371-373.
190. + T lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 69:5236-5242.
191. Moriuchi, H., M. Moriuchi, H. A. Smith, and J. I. Cohen. 1994. Varicella-zoster virus open reading frame 4 protein is functionally distinct from and does not complement is herpes simplex virus type 1 homolog, ICP27. J. Virol. 68:1987-1992.
192. Myers, M. 1979. Viremia caused by varicella-zoster virus: association with malignant progressive varicella. J. Infect. Dis. 140:229-232.
193. Myers, M. G., L. R. Stanberry, and B. J. Edmond. 1985. Varicella-zoster virus infection of strain 2 guinea pigs. J. Infect. Dis. 151:106-113.
194. Nader, S., R. Bergen, M. Sharp, and A. M. Arvin. 1995. Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine. J. Infect. Dis. 171:13-17.
195. Nahass, G. T., M. J. Mandel, S. Cook, W. Fan, and C. L. Leonardi. 1995. Detection of herpes simplex and varicella-zoster infection from cutaneous lesions in different clinical stages with the polymerase chain reaction. J. Am. Acad. Dermatol. 32:730-733.
196. Ooi, P. L., K. T. Goh, S. Doraisingham, and A. E. Ling. 1992. Prevalence of varicella-zoster virus infection in Singapore. Southeast Asian J. Trop. Med. Public Health 23:22-25.
197. Ozaki, T., T. Ichikawa, Y. Matsui H. Kondo, T. Nagai, Y. Asano, K. Yamanishi, and M. Takahashi. 1986. Lymphocyte-associated viremia in varicella. J. Med. Virol. 19:249-253.
198. Ozaki, T., Y. Kajita, Y. Asaao, T. Aono, and K. Yamanishi. 1994. Detection of varicella-zoster virus DNA in blood of children with varicella. J. Med. Virol. 44:263-265.
199. Ozaki, T., S. Masuda, Y. Asano, K. Kondo, J. Namazue, and K. Yamanishi. 1994. Investigation of varicella-zoster virus DNA by the polymerase chain reaction in healthy children with varicella vaccination. J. Med. Virol. 42: 47-51.
200. Ozaki, T., H. Miwata, Y. Asano, J. Namazue, and K. Yamanishi. 1993. Varicella zoster virus DNA in throat swabs of vaccinees. Arch. Dis. Child. 267:328-329.
201. Pahwa, S., K. Biron, W. Lim, P. Swenson, M. H. Kaplan, N. Sadick, and R. Pahwa. 1988. Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. JAMA 260:2879-2882.
202. Paryani, S. G., and A. M. Arvin. 1986. Intrauterine infection with varicella-zoster virus after maternal varicella. N. Engl. J. Med. 314:1542-1546.
203. Pastuszak, A. L., M. Levy, B. Schick, C. Zuber, M. Feldkamp, J. Gladstone, F. Bar-Levy, E. Jackson, A. Donnenfeld, and W. Meschino. 1994. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N. Engl. J. Med. 330:901-905.
204. Patterson, L. E., K. M. Butler, and M. S. Edwards. 1989. Clinical herpes zoster shortly following primary varicella in two HIV-infected children. Clin. Pediatr. 28:354-359.
205. Peck, R. W., R. Wootton, D. R. Lee, S. H. Jackson, and J. Posner. 1995. The bioavailability and disposition of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil (882C87), a potent, new anti-varicella zoster virus agent. Br. J. Clin. Pharmacol. 39:143-149.
206. Perera, L. P., S. Kaushal, P. R. Kinchington, J. D. Mosca, G. S. Hayward, and S. E. Straus. 1994. Varicella-zoster virus open reading frame 4 encodes a transcriptional activator that is functionally distinct from that of herpes simplex virus homology ICP27. J. Virol. 68:2468-2477.
207. Perera, L. P., J. D. Mosca, W. T. Ruyechan, and J. Hay. 1992. Regulation of varicella-zoster virus gene expression in human T lymphocytes. J. Virol. 66:5298-5304.
208. Perez, J. L., A. Garcia, J. Niubo, J. Salva, D. Podzamczer, and R. Martin. 1994. Comparison of techniques and evaluation of three commercial monoclonal antibodies for laboratory diagnosis of varicella-zoster virus in mucocutaneous specimens. J. Clin. Microbiol 32:1610-1613.
209. Perren, T. J., R. L. Powles, D. Easton, K. Stolle, and P. J. Selby, 1988. Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation. Am. J. Med. 85:99-101.
210. Peters, A. C. B., J. Versteeg, J. Lindman, and G. T. A. M. Bots. 1978. Varicella and acute cerebellar ataxia. Arch. Neucol. 35:769-784.
211. Plotkin, S. A., S. E. Starr, K. Connor, and D. Morton. 1989. Zoster in normal children after varicella vaccine. J. Infect. Dis. 159:1000-1001.
212. Portenoy, R. K., C. Duma, and K. M. Foley. 1986. Acute herpetic and post-herpetic neuralgia: clinical review and current management. Ann. Neurol. 20:651-664.
213. Poscher, M. E. 1994. Successful treatment of varicella zoster virus meningoencephalitis in patients with AIDS: report of four cases and review. AIDS 8:1115-1117.
214. Preblud, S. R. 1981. Age specific risks of varicella complications. Pediatrics 68:14-18.
215. Preblud, S. R. 1986. Varicella: complications and costs. Pediatrics 78:728-735.
216. Preblud, S. R., D. J. Bregman, and L. L. Vernon. 1985. Deaths from varicella in infants. Pediatr. Infect. Dis. J. 4:503-507.
217. Preblud, S. R., W. A. Orenstein, and K. J. Bart. 1984. Varicella: clinical manifestations, epidemiology, and health impact in children. Pediatr. Infect. Dis. J. 3:505-509.
218. Prober, C. G., A. A. Gershon, C. Grose, G. H. McCracken, Jr., and J. D. Nelson. 1990. Consensus: varicella-zoster infections in pregnancy and the perinatal period. Pediatr. Infect Dis. J. 9:865-869.
219. Prober, C. G., L. E. Kirk, and R. E. Keeny. 1982. Acyclovir therapy of chickenpox in immunosuppressed children: a collaborative study. J. Pediatr. 101:622-625.
220. Purifoy, D. J., L. M. Beauchamp, P. De Miranda, P. Ertl, S. Lacey, G. Roberts, S. G. Rahim, G. Darby, T. A. Krenitsky, and K. L. Powell. 1993. Review of research leading to new anti-herpesvirus agents in clinical de velopment: valaciclovir hydrochloride (256U, the L-valyl ester of acyclovir) and 882C, a specific agent for varicella zoster virus. J. Med. Virol. Suppl. 1:139-145.
221. Ragozzino, M. W., L. J. Melton III, L. T. Kurland, C. P. Chu, and H. O. Perry. 1982. Population-based study of herpes zoster and its sequelae. Medicine 61:310-316.
222. Ragozzino, M. W., L. J. Melton III, L. T. Kurland, C. P. Chu, and H. O. Perry. 1982. Risk of cancer after herpes zoster: a population based study. N. Engl. J. Med. 307:393-397.
223. Rawlinson, W. D., D. E. Dwyer, V. L. Gibbons, and A. L. Cunningham. 1989. Rapid diagnosis of varicella-zoster virus infection with a monoclonal antibody based direct immunofluorescence technique. J. Virol Methods 23:13-18.
224. Beichman, R. C. 1978. Neurologic complications of varicella-zoster infections. Ann. Intern. Med. 375:89-96.
225. Ross, A. H. 1962. Modification of chickenpox in family contacts by administration of gamma globulin. N. Engl. J. Med. 267:369-376.
226. Sadzot-Delvaux, C., M. P. Merville-Louis, P. Delree, P. Marc, J. Piette, G. Moonen, and B. Rentier. 1990. An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia. J. Neurosci. Res. 26:83-89.
227. Safrin, S., T. G. Berger, I. Gilson, P. R. Wolfe, C. B. Wofey, J. Mills, and K. K. Biron. 1991. Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection. Ann. Intern. Med. 115:19-21.
228. Saltzman, R., R. Jurewicz, and R. Boon. 1994. Safety of famciclovir in patients with herpes zoster and genital herpes. Antimicrob. Agents Chemother. 38:2454-2457.
229. Sawyer, M. H., C. J. Chamberlin, Y. N. Wu, N. Aintablian, and M. R. Wallace. 1994. Detection of varicella-zoster virus DNA in air samples from hospital rooms. J. Infect. Dis. 169:91-94.
230. Sawyer, M. H., Y. N. Wu, C. Chamberlin, C. Burgos, S. K. C. Brodine, W. A. Bowler, A. LaRocco, E. C. Oldfield III, and M. R. Wallace. 1992. Detection of varicella-zoster virus DNA in the oropharynx and blood of patients with varicella. J. Infect. Dis. 166:885-888.
231. Schmader, K., L. K. George, B. M. Burchett, C. F. Pieper, and J. D. Hamilton. 1995. Racial differences in the occurrence of herpes zoster. J. Infect. Dis. 171:701-704.
232. Schmidbauer, M., H. Budka, P. Pilz, T. Kurata, and R. Hondo. 1992. Presence, distribution and spread of productive varicella zoster virus infection in nervous tissues. Brain 115:383-398.
233. Schmidt, N. J., D. Gallo, Y. Devlin, J. D. Woodie, and R. W. Emmons. 1980. Direct immunofluorescence staining for detection of herpes simplex and varicella-zoster virus antigens in vesicular lesions and certain tissue specimens. J. Clin. Microbiol. 12:651-655.
234. Schuchter, L. M., J. R. Wingard, S. Piantadosi, W. H. Burns, G. W. Santos, and R. Saral. 1989. Herpes zoster infection after autologous bone marrow transplantation. Blood 74:1424-1427.
235. Sharp, M., K. Terada, A. Wilson, S. Nader, P. E. Kinchington, W. Ruyechan, J. Hay, and A. M. Arvin. 1992. Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine. J. Infect. Dis. 165:852-858.
236. Shiraki, K., H. Othiai, S. Matsui, N. Aiba, Y. Yoshida, T. Okuno, K. Yamanishi, and M. Takahashi. 1992. Processing of hepatitis B virus surface antigen expressed by recombinant Oka varicella vaccine virus. J. Gen. Virol. 73:1401-1407.
237. Siegel, M., H. T. Fuerst, and N. S. Press. 1966. Comparative fetal mortality in maternal virus diseases: a prospective study on rubella, measles, mumps, chickenpox and hepatitis. N. Engl. J. Med. 274:768-774.
238. Spector, T., J. A. Harrington, R. W. Morrison, Jr., C. U. Lambe, D. J. Nelson, D. R. Averett, K. Biron, and P. A. Furman. 1989. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir. Proc. Natl. Acad. Sci. USA 86:1051-1055.
239. Srugo, I., V. Israele, A. E. Wittek, T. Courville, V. M. Vimal, and P. A. Brunell. 1993. Clinical manifestations of varicella-zoster virus infections in human immunodeficiency virus-infected children. Am. J. Dis. Child. 147: 742-745.
240. Starr, S. E. 1992. Varicella in children receiving steroids for asthma: risks and management. Pediatr. Infect. Dis. J. 11:419-420.
241. Steinberg, S. P., and A. A, Gershon. 1991. Measurement of antibodies to varicella-zoster virus by using a latex agglutination test. J. Clin. Microbiol. 29:1527-1529.
242. Stevens, D. A., and T. C. Merigan. 1980. Zoster immune globulin prophylaxis of disseminated zoster in compromised hosts. Arch. Intern. Med. 140:52-54.
243. Straus, S. E. 1989. Clinical and biological differences between recurrent herpes simplex virus and varicella-zoster virus infection. JAMA 262:3455-3458.
244. Straus, S. E., and J. L. Meier. 1992. Comparative biology of latent varicella-zoster virus and herpes simplex virus infections. J. Infect. Dis. 166(Suppl. 1):S13-S23.
245. Straus, S. E., W. Reinhold, H. A. Smith, W. T. Ruyechan, D. K. Henderson, R. M. Blaese, and J. Hay. 1984. Endonuclease analysis of viral DNA from varicella and subsequent zoster infection in the same patient. N. Engl. J. Med. 311:1362-1364.
246. Takabashi, M. 1992. Current status and prospects of live varicella vaccine. Vaccine 10:1007-1014.
247. Tsolia, M., A. A. Gershon, S. P. Steinberg, and L. Gelb. 1990. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. J. Pediatr. 116:184-189.
248. Vafai, A., M. Wellish, and D. H. Gilden. 1988. Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia. Proc. Natl. Acad. Sci. USA 85:2767-2770.
249. Vere Hodge, R. A., D. Sutton, M. R. Boyd, M. R. Harnden, and R. L. Harvest. 1989. Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxyl-3-hydroxymethylbut-1-yl)guanine; penciclovir]. Antimicrob. Agents Chemother. 33:1765-1773.
250. von Bókay, J. 1909. Über den ätiologischen Zusammenhang der Varizellen mit gewissen Fällen von Herpes Zoster. Wien. Klin. Wochenschr. 22:1323-1326.
251. Wallace, M. R., W. A. Bowler, N. B. Murray, S. K. Brodine, and E. C Oldfield III. 1992. Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial. Ann. Intern. Med. 17:358-363.
252. Wallace, M. R., C. J. Chamberlin, M. H. Sawyer, A. M. Arvin, J. Harkins, A. Larocco, W. A. Bowler, and E. C. Oldfield III. Treatment of adult varicella with sorivudine: a randomized, placebo controlled trial. Submitted for publication.
253. Watson, B., C. Boardman, D. Laufer, S. Piercy, N. Tustin, D. Olaleye, A. Cnaan, and S. E. Starr. 1995. Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine. Clin. Infect. Dis. 20:316-319.
254. Watson, B., R. Gupta, T. Randall, and S. Starr. 1994. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine. J. Infect Dis. 169:197-199.
255. Watson, B. M., S. A. Piercy, S. A. Plotkin, and S. E. Starr, 1993. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 91:17-22.
256. Watson, C. P. N., and J. H. Deck. 1993. The neuropathology of herpes zoster with particular reference to postherpetic neuralgia and its pathogenesis, p. 139-157. In C. P. N. Watson (ed.), Herpes zoster and postherpetic neuralgia. Pain research and clinical management, vol. 8. Biomedical Press, Amsterdam.
257. Webster, C. B., D. Chen, M. Horgan, and P. D. Olivo. 1995. The varicella-zoster virus origin-binding protein can substitute for the herpes simplex virus origin-binding protein in a transient origin-dependent DNA replication assay in insect cells. Virology 206:655-660.
258. Weibel, R. E., B. J. Neff, B. J. Kuter, H. A. Guess, C. A. Rothenberger, A. T. Fitzgerald, K. A. Connor, A. A. McLean, M. R. Hilleman, and E. B. Buynak. 1984. Live attenuated varicella virus vaccine: efficacy trial in healthy children. N. Engl. J. Med. 310:1409-1415.
259. Weller, T. H. 1992. Varicella and herpes zoster, a perspective and overview. J. Infect. Dis. 166(Suppl. 1):S1-S7.
260. White, C. J., B. J. Kuter, C. S. Hildebrand, K. L. Isganitis, H. Matthews, W. J. Miller, P. J. Provost, R. W. Ellis, R. J. Gerety, and G. B. Calaudra. 1991. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989: Pediatrics 87:604-610.
261. Whitley, R. J. 1990. Varicella-zoster virus infections, p. 235-263. In G. J. Galasso, R. J. Whitley, and T. C. Merigan (ed.), Antiviral agents and viral diseases of man. Raven Press, New York.
262. Whitley, R. J. 1992. Therapeutic approaches to varicella-zoster virus infections. J. Infect. Dis. 166(Suppl. 1):S51-S57.
263. Wilson, A., M. Sharp, C. M. Koropchak, S. F. Ting, and A. M. Arvin. 1992. Subclinical varicella-zoster virus viremia, herpes zoster and recovery of T-lymphocyte responses to varicella-zoster viral antigens after allogeneic and autologous bone marrow transplantation. J. Infect. Dis. 165:119-126.
264. Wishik, S. M., and J. G. M. Bullowa. 1935. Complications of varicella. II. Surface complications. Am. J. Dis. Child. 49:927-939.
265. Wood, M. J., R. W. Johnson, M. W. McKendrick, J. Taylor, B. K. Mandal, and J. Crooks. 1994. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N. Engl. J. Med. 330:896-900.
266. Wood, M. J., M. W. McKendrick, and J. I. McGill. 1987. Oral acyclovir for acute herpes zoster infections in immune-competent adults. Infection 15: S9-S13.
267. Wood, M. J., P. H. Ogan, M. W. McKendrick, C. D. Care, J. I. McGill, and E. M. Webb. 1988. Efficacy of oral acyclovir treatment of acute herpes zoster. Am. J. Med. 85(2A):79-83.
268. Zaia, J. A., M. J. Levin, S. R. Preblud, J. Leszczynski, G. G. Wright, R. J. Ellis, A. C. Curtis, M. A. Valerio, and J. LeGore. 1983. Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J. Infect Dis. 147:737-743.
269. Zhang, Y., M. Cosyns, M. J. Levin, and A. R. Hayward. 1994. Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin. Exp. Immunol. 98:128-133.
270. Zhu, Z., M. D. Gershon, R. Ambron, C. Gabel, and A. A. Gershon. 1995. Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin. Proc. Natl. Acad. Sci. USA 92:3546-3550.